Cite
HARVARD Citation
Hsieh, Y. et al. (2016). Angiotensin-Receptor Blocker, Angiotensin-Converting Enzyme Inhibitor, and Risks of Atrial Fibrillation. Medicine. 95 (20), p. . [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Hsieh, Y. et al. (2016). Angiotensin-Receptor Blocker, Angiotensin-Converting Enzyme Inhibitor, and Risks of Atrial Fibrillation. Medicine. 95 (20), p. . [Online].